SCHEMBL18683036

SCHEMBL18683036

O=C(O)CC(CF)c1cc(Br)ccc1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 1/20 0.37
FFAR1 O14842 1/20 0.35
GABBR2 O75899 4/20 0.34
GABBR1 Q9UBS5 4/20 0.34
LMNA P02545 2/20 0.34
CYP2C9 P11712 2/20 0.34
CYP3A4 P08684 1/20 0.34
ADORA3 P0DMS8 1/20 0.34
NFKB1 P19838 1/20 0.34
DRD3 P35462 1/20 0.34
BLM P54132 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C19 P33261 1/20 0.34
MEN1 O00255 1/20 0.34
THRB P10828 1/20 0.34
TSHR P16473 1/20 0.34
KMT2A Q03164 1/20 0.34
IDO1 P14902 1/20 0.34
TDO2 P48775 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18683293 0.80 NPSR1 (0.39) LMNAADORA3MEN1TSHRKMT2A
SCHEMBL18683291 0.79 AAK1 (0.40)
SCHEMBL17144551 0.79 DGAT1 (0.43) DGAT1FFAR1LMNAMEN1KMT2A
SCHEMBL18682916 0.78 DGAT1 (0.32) DGAT1
SCHEMBL18683038 0.78 DGAT1 (0.32) DGAT1CYP2C9CYP1A2CYP2D6CYP2C19
SCHEMBL18683363 0.77 EEF2K (0.46) GABBR2GABBR1MEN1KMT2AEEF2K
SCHEMBL18683365 0.74 LMNA (0.35) LMNAHPGD
SCHEMBL31462768 0.73 GABBR2 (0.49) GABBR2GABBR1LMNACYP2C9CYP3A4
SCHEMBL23294489 0.72 PTGFR (0.36) GABBR2GABBR1CYP3A4HPGDCTSA
SCHEMBL21677164 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3353163-B1 2,3,4,5-TETRAHYDROPYRIDIN-6-AMINE DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 2020-02-05 EP disclosed
WO-2017050978-A1 2,3,4,5-TETRAHYDROPYRIDIN-6-AMINE DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 2017-03-30 WO disclosed